Eric Nicol

National caregiving strategy including necessary policy, program, and budgetary allocations. Convert the Canada Caregiver Credit into a refundable tax-free benefit.

Avis de la FADOQ sur le Projet de loi C-263 pour la mise en place d'une alerte Silver au Canada La bonification du Programme d'adaptation de Postes Canada pour la livraison du courrier à domicile pour les personnes aînées. Démarches afin de rendre les peines sur les fraudes visant les personnes ainées plus sévères. Les démarches visent les politiques et programmes reliés à la santé des aînés afin d'améliorer les soins de santé, leur financement, ainsi que l'accès des professionnels de santé qualifiés. Démarches afin de rendre les personnes retraitées et aînées admissibles au versement la Remise pour les travailleurs canadiens. Démarches afin de bonifier les diverses aides destinées aux aînés telles que la pension de la Sécurité de la vieillesse.

Veterans Independence Program, respecting extension to Royal Canadian Mounted Police veterans. Royal Canadian Mounted Police Superannuation Act, respecting marriage after retirement or over the age of 60; immediate indexation of Canadian Forces Superannuation Act and Royal Canadian Mounted Police Superannuation Act pensions; pension plan funding and security of benefits; and Pension Advisory Committee. Registered Retirement Savings Plans, Registered Retirement Income Fund and Tax Free Savings Accounts, respecting coordination and enhancement of programs. Public Service Superannuation Act, respecting annual statement of benefits for pensioners. Public Service Health Care Plan and Pensioner Dental Service Plan, respecting coordination of plans and maintenance/enhancement. Previously known as Bill C-357 of the 42nd Parliament, An Act to amend the Public Service Superannuation Act (Group 1 contributors); with respect to discussions with government officials the implications of this bill and current legislation on retirees, and the need to fix a gap that emerged following 2012 changes to the federal public service pension plan (specifically, veterans who transfer their pensionable military service to the public service pension plan after 2013 are subject to a later retirement date, even though they have served Canada prior to the cut-off date). Policies and programs which may enhance and protect the rights and well-being of veterans and their families, included, but not limited to The Veterans Well-being Act (S.C. 2005, c. 21), the Pension Act, R.S.C. 1985, c. P-6 as amended and the Veterans Benefit Act, R.S.C. 1970, V-2 as amended. Old Age Security and Guaranteed Income Supplement, respecting coordination and enhancement of programs. Marriage after retirement or over the age of 60; Pension Advisory Committee; pension plan funding and security of benefits. Maintain Canada Health Act and equitable health care access. Implementation of a national pharmacare program that responds to recommendations made by the Advisory Council on the Implementation of National Pharmacare. Government of Canada Workplace Charitable Campaign (GCWCC) and recognition of Federal Retiree as the leading representative body for retirees (or retired public servants, members of the CAF and members of the RCMP). Ensure that the Pension Benefit Standards Act remains unchanged with respect to protecting defined benefit pension plans and changes that would undermine them. Discussions with government officials to ensure and discuss the progress of implementing a national seniors strategy which will encourage and promote the wellness and independence of older Canadians. Canadian Forces and Public Service Supplementary Death Benefit, respecting discriminatory differences. Canada Pension Plan/Quebec Pension Plan, respecting coordination of superannuation plans and enhancement.

The Canadian ETF Association is looking to promote its organization and its priorities with the relevant Parliamentarians, public servants and political staff who have a role in legislating, or an interest in, financial institutions, investments and pensions. Efforts will focus on advancing priorities to strengthen Canada’s investment landscape, restricting distribution incentives for non-Canadian ETFs, and creating tax-advantaged accounts to promote fixed income ETFs.

Encouraging more effective use of TFSAs. Tax fairness and competitiveness with the U.S.

Improve Federal immigration and workforce strategies to support the workforce of today and tomorrow. Elevate senior living’s role in the continuum of housing, care and support services. Advocate for Federal tax policies that address affordability for seniors choosing to live in senior living. Advance Federal policy to facilitate and alleviate barriers for capital investment and development in senior living.

Engage with government to strengthen the Priority Review of Drug Submissions process. The Government of Ontario has passed legislation requiring the public disclosure of payments made to Health Care Providers and Health Care Organizations by the broader health care industry, including pharmaceutical companies, generic manufacturers, and medical device companies. GlaxoSmithKline seeks to advocate for a national approach to disclosure through either the support of similar provincial initiatives, coordinated action through the Federal / Provincial and Territorial meetings of the Ministers of Health, and / or the establishment of national requirements. Sharing information with government and Members of Parliament on different models for national pharmacare, specifically as it relates to access to medicines. Renewal of national vaccine strategy to close gaps in vaccination coverage for Canadians, especially among seniors. Reforms to the Patented Medicines Review Board (PMPRB), whose guidelines seek to ensure a balance between the prices set by manufacturers for patented medicines sold in Canada and the maintenance of an attractive environment for pharmaceutical research and development. Specifically with regard to ensuring that any actions and proposed changes by the PMPRB do not negatively impact access to patented medicines in Canada. Raise awareness regarding the potential risks to drug and vaccine supply for Canadian patients arising from new U.S. state-level reimportation legislation. Participation in consultations regarding the Digital Charter and the federal government's plans to overhaul Canada's privacy regime, to enable the use of anonymized health data for new medication research and development. Input on the work of the Advisory Committee on the Implementation of National Pharmacare, specifically as it relates to access to medicines. Harmonizing rules for the sampling of natural health products under the proposed Canada-United States-Mexico trade agreement. Ensure the National Advisory Committee on Immunization has sufficient resources to undertake timely reviews of new vaccines that are made available to the Canadian marketplace. Engaging Health Canada on the Self-Care Products Initiative as it pertains to plain language labelling and a risk-based approach to regulatory oversight for non prescription drugs. Engage the government regarding the need for clear and efficient procurement processes for COVID-19 medical countermeasures, including COVID-19 therapeutics, to ensure access for Canadians. Engagement with government officials on disruptions to business, health & safety requirements, and opportunities to help with the COVID-19 pandemic. Engage government officials regarding domestic manufacturing of seasonal and pandemic flu vaccine. Antimicrobial Resistance (AMR) - Identification of the need for a multi-sectoral stakeholder working group to pursue joint goals under a Pan-Canadian AMR strategy and to strengthen Canada's end-to-end research capacity in AMR. Allow for the regulation of products containing cannabidiol (CBD) as natural health products.

Engagement with the Government regarding the Life Science Fund seeking partnership and funding to support completion of Phase I and Phase II clinical research program associated to AMR (antimicrobial resistance) Antimicrobial Resistance (AMR) - Seek funding and support for pilot projects making anti-infective medications available to equity seeking populations, helping to combat AMR. Also discuss any applicable conditions regarding this funding. Programs and policy to support Canadian biomanufacturing and access to medicines and vaccines for Canadians. National Immunization Strategy and policies and programs that impact public access to vaccines and disease prevention in Canada. Patented Medicines Review Board (PMPRB), certified under the Patent Act and whose guidelines seek to ensure a balance between the prices set by manufacturers for patented medicines sold in Canada and the maintenance of an attractive environment for pharmaceutical research and development. Engagement with federal officials regarding the Biomanufacturing & Life Sciences Strategy and policies and programming related to biomanufacturing in Canada Access to medicines - government policies, processes, legislation, and/or regulation with potential impact on access to medicines in Canada. Trade-related matters, including policies and tariffs impacting medicines and vaccines. Policies and programs related to the health of new immigrants to Canada. Policies, programs, and funding related to Canada's Sexually Transmitted and Blood-Borne Infections (STBBI) Action Plan 2024-2030. Engagement with federal officials regarding Health Emergency Readiness Canada. The National Pharmaceutical Strategy (NPS) as agreed by First Ministers in 2004. Advocacy for ways to increase access to medicines and vaccines for Canadian patients. The Common Drug Review (CDR) process for reviewing new drugs and providing listing recommendations to publicly funded drug benefit plans in Canada. Ensuring the access needs of Canadian patients are met by advocating on activities undertaken in the context of the CDR. Science and Technology (S&T) Strategy: Mobilizing Science and Technology to Canada's Advantage. Advocacy for measures which will allow for commercialization in health care to occur and for Canada to remain competitive internationally on Intellectual Property and other fronts. Public Services and Procurement Canada (PSPC) Integrity Framework - Clarifying the process for procurement of vaccines and possibly pharmaceuticals under the evolving procurement framework. Patented Medicines (Notice of Compliance) Regulations which seek to balance the protection of Intellectual Property (IP) and patents with cost containment. Advocacy to ensure that IP rights are respected and internationally competitive in order to promote Research and Development. Legislation, regulations, policies and programs concerning the federal government's response to COVID-19, including pandemic preparedness, pharmaceutical and vaccine supply-chain management, and general administration of justice. Food and Drugs Act and the bill formerly known as Bill C-51: An Act to amend the Food and Drugs Act and to make consequential amendments to other Acts. Specifically, with respect to the renewal of the drug approval process. Advocacy to ensure that Canada's review and approval process is timely, safe, effective, competitive and consistent with other jurisdictions. FedDev Ontario Advanced Manufacturing Fund - advancing manufacturing of innovative pharmaceutical products in southern Ontario Engage with government to strengthen the Priority Review for Drug Submissions process. Engage the Government regarding the need for clear and efficient procurement processes for COVID-19 medical countermeasures, including COVID-19 therapeutics, to ensure access for Canadians. Engagement with the Government regarding the Strategic Innovation Fund Drug Re-importation - Raise awareness regarding the potential risks to drug and vaccine supply fo

Federal role in the health system as it relates to funding, the use of federal spending power, and pan-Canadian priorities, including in the areas of physical and digital infrastructure, health workforce, immigration, aging, older adult care, child and youth health, mental health and substance use, palliative care, cybersecurity, Indigenous health, environment, and data. Advancing Canada’s health research and innovation agenda as it relates to funding, policy and program design, and regulatory matters, including in the areas of clinical trials and development of innovative medical treatments.

Increase investment and access to funding for health research, innovation, knowledge translation and commercialization. Mental health and well-being support and services for the health workforce and Canadian public. Allow direct access to federal funding for academic healthcare organizations (healthcare delivery organizations, research institutes and health authorities). Improve Indigenous health services and access to care for Indigenous people, and continue to act on Truth and Reconciliation Commission recommendations. Improve access and quality of palliative care. Implement national standards for long-term care. Funding and programs to improve healthcare infrastructure energy efficiency and climate and pandemic resiliency. Funding and programs to support virtual care, digital health, and cybersecurity in the health sector. Secure an innovation supercluster in the health and life sciences so that this sector can be supported as one of Canada's world-leading innovation clusters. Funding for cybersecurity resiliency and standards in the health sector. Increase funding to modernize critical physical and digital health infrastructure to support the delivery of health services and health research and innovation. Funding, policies and programs related to clinical trials, medications/drugs and medical devices. Create a more equitable, diverse, inclusive and representative health system that reflects the Canadian population and serves the needs of all Canadians. Implement measures and funding to prevent opioid addiction and overdoses, and to improve access to and implementation of appropriate harm reduction programs and treatments. Federal role in the health system as it relates to the use of federal spending power and the achievement of national objectives. Health services to populations falling under federal jurisdiction, like veterans and certain Indigenous people. Improve the delivery of older adult care in Canada, including a shift to providing more home and community care and creating communities that allow for healthy aging. Implement recommendations from the Industry Strategy Council's "Restart, recover, and reimagine prosperity for all Canadians" report, including policy and program changes and increasing investments in the health and biosciences sector. Implement a national health human resources strategy to address staffing shortages and inadequate level of primary care providers and improve working conditions in the health system.

Discussion of upskilling cyber security capabilities within the workforce of law enforcement to combat domestic and transnational crime. A conversation regarding AI-focused data centre infrastructure in Canada, including dedicated sovereign capacity, to retain economic value, strengthen domestic innovation capacity, and reinforce Canada’s position as a global AI leader. Introduction to the Rogers' Cybersecure Catalyst's mandate and scope of work across cybersecurity training, entrepreneurship, research, policy development, and public education for individuals, entrepreneurs, and organizations of all sizes. Discussion to support robust government regulation to curb harmful content, with calls for measures addressing online harms such as removing child sexual abuse material, labelling AI-generated content, and increasing parental controls. Discussion regarding the development of an AI Intelligence Unit to supplement the work of Artificial Intelligence (AI) and Technology Measurement Program (TechStat) Briefed about community based seniors services sector. Discussed Aging with Dignity bilateral agreements. Suggested amendments on Bill C-16 about coercive control to include non-intimate partner relationships (relatives and caregivers) to ensure equal protection for older adults. Email with an endorsed letter supporting TMU's National Institute on Aging's proposal for amending the Canadian Pension Plan to implement a Pension Delay Guarantee policy Conversation about TMU's Creative School and the implications of Artificial Intelligence and workforce development, SME adoption, applied research, and sector-wide innovation in the creative sector Conversation about TMU's National Institute on Aging's proposal for amending the Canadian Pension Plan to implement a Pension Delay Guarantee policy Discussion about the innovation economy, emerging technology, and business adoption with government leaders as part of the Innovative Economy table with the Canadian Chamber of Commerce Discussion of National Cyber Strategy and its integration with specific needs for small and medium businesses related to workforce development Discussion of cyber capacity building in Indo-Pacific Region and Latin America Conversation about innovation in housing as a follow-up to funding that was received from Federal Economic Development Agency for Southern Ontario for the Centre for Housing Innovation Conversation regarding the development and adaption dual-use technology Conversation about IP Clinic Program, specifically regarding client and student experiences within the program and about Canada’s IP landscape. Conversation with FedDev ON to discuss a funding proposal for building national defence capacity and a discussion about programming to include supporting ON based SMBs to position themselves to sell into Canadian defence supply chains Discussion to introduce the Diversity Institute and it's work to the policy team at WAGE Conversation about the Industrial Research Program with the new advisor to help with advice, connections, and to help with Canadian small and medium-sized businesses increase their innovation capacity. Discussion about a potential project at TMU's School of Engineering Discussing artificial intelligence, adoption, and impacts on workforce skills/labour market. Conversation about veteran transition and mental health initiatives that the university offers Conversation about financial literacy and tax education research Conversation about arctic and northern community research Conversation about workforce development to drive innovation and collaboration in the labour market by developing digital solutions and fostering partnerships that enhance connectivity and inclusivity and creating Northern Ontario partnerships Conversation about the modernization of student financial aid and digital inclusion Discussion about school of medicine and health force expansion Conversation around capital funding and student housing Conversation about primar

Examination of Funding programs to support adult literacy

Ongoing government engagement activities related to any future legislative changes impacting long-term care and seniors’ housing, including national standards, affordable, and supportive housing.